Recombinant fusion protein of human SHC4(NP_976224.3).
Conjugation:
Unconjugated
Alternative Names:
SHC4,RaLP,SHCD
Predicted to enable receptor tyrosine kinase binding activity. Predicted to be involved in transmembrane receptor protein tyrosine kinase signaling pathway. Predicted to act upstream of or within several processes, including apoptotic process, positive regulation of cell population proliferation, and stem cell differentiation. Predicted to be located in postsynaptic membrane. Predicted to be active in plasma membrane.
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).
Form:
1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2
Application Dilute:
WB,1:500 - 1:2000|IF/ICC,1:50 - 1:200
Application Notes:
Polyclonal Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
